Singapore, March 28 -- The Health Sciences Authority received information related to the study titled 'A Phase 3 Open-label Randomized Study Assessing the Efficacy and Safety of RLY-2608 + Fulvestrant... और पढ़ें
Singapore, March 28 -- The Health Sciences Authority received information related to the study titled 'A randomized, double-blind, placebo-controlled study to evaluate the effect of dupilumab on airwa... और पढ़ें
Singapore, March 28 -- The Health Sciences Authority received information related to the study titled 'A randomized, double-blind, placebo-controlled study to evaluate the effect of dupilumab on airwa... और पढ़ें
Singapore, March 28 -- The Health Sciences Authority received information related to the study titled 'MK-5684-015: A Multicenter, Open-label, Phase 2 Basket Study of MK-5684 in Participants With Sele... और पढ़ें
Singapore, March 28 -- The Health Sciences Authority received information related to the study titled 'CA088-1007: A Phase 3, Randomized, Open-Label, Multicenter Study to Compare the Efficacy and Safe... और पढ़ें
Singapore, March 28 -- The Health Sciences Authority received information related to the study titled 'A Multinational, Multicenter, Prospective, Randomized, Controlled, Open-Label, Phase 3 Study of L... और पढ़ें
Singapore, March 28 -- The Health Sciences Authority received information related to the study titled 'A phase I open-label, multi-center study to evaluate the safety, tolerability, dosimetry, and pre... और पढ़ें
Singapore, March 28 -- The Health Sciences Authority received information related to the study titled 'CO45042: A Phase III, Randomized, Open-Label Study Evaluating the Efficacy and Safety of Divarasi... और पढ़ें
Singapore, March 28 -- The Health Sciences Authority received information related to the study titled 'A Phase 3 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Impact of Maridebart... और पढ़ें
Singapore, March 28 -- The Health Sciences Authority received information related to the study titled 'A Single-Arm, Phase IIIb Global, Multi-center Study of Durvalumab in Combination with Tremelimuma... और पढ़ें